跳到正文

ADAR1 Capital Management, LLC 内部人交易:近期 SEC Form 4 交易

过去 18 个月,ADAR1 Capital Management, LLC(CIK 1940272)在 6 家公司共报告 69 笔 SEC Form 4 内部人交易(最近一笔 2026-11-13)。

日期公司身份类型股数市值
2026-11-13NextCure, Inc. (NXTC)10% 以上股东买入12,333$62,897
2026-11-09InMed Pharmaceuticals Inc. (MTRI)10% 以上股东买入2,640$34,572
2026-11-09NextCure, Inc. (NXTC)10% 以上股东买入1,024$5,222
2026-11-09NextCure, Inc. (NXTC)10% 以上股东买入3,662$18,676
2026-10-27InMed Pharmaceuticals Inc. (INM)10% 以上股东买入4$5
2026-10-27NextCure, Inc. (NXTC)10% 以上股东买入5,626$27,170
2026-10-27NextCure, Inc. (NXTC)10% 以上股东买入1,672$8,418
2026-10-27NextCure, Inc. (NXTC)10% 以上股东买入3,553$18,104
2026-10-21TENAX THERAPEUTICS, INC. (TENX)10% 以上股东买入336,528$507,013
2026-10-21TENAX THERAPEUTICS, INC. (TENX)10% 以上股东买入254,342$405,726
2026-10-21TENAX THERAPEUTICS, INC. (TENX)10% 以上股东买入331,979$550,687
2026-10-20InMed Pharmaceuticals Inc. (INM)10% 以上股东买入1,086$1,434
2026-10-20InMed Pharmaceuticals Inc. (INM)10% 以上股东买入1$1
2026-10-15InMed Pharmaceuticals Inc. (INM)10% 以上股东买入564$750
2026-10-15InMed Pharmaceuticals Inc. (INM)10% 以上股东买入8,021$10,668
2026-10-15InMed Pharmaceuticals Inc. (INM)10% 以上股东买入984$1,301
2026-10-08InMed Pharmaceuticals Inc. (INM)10% 以上股东买入5,601$7,436
2026-10-08InMed Pharmaceuticals Inc. (INM)10% 以上股东买入3,046$4,051
2026-10-08InMed Pharmaceuticals Inc. (INM)10% 以上股东买入2,256$2,997
2026-10-05InMed Pharmaceuticals Inc. (INM)10% 以上股东买入16,431$21,850
2026-10-05InMed Pharmaceuticals Inc. (INM)10% 以上股东买入8,307$11,048
2026-10-05InMed Pharmaceuticals Inc. (INM)10% 以上股东买入18,182$24,182
2026-09-16InMed Pharmaceuticals Inc. (INM)10% 以上股东买入28,505$36,771
2026-09-16InMed Pharmaceuticals Inc. (INM)10% 以上股东买入54,256$70,533
2026-09-16InMed Pharmaceuticals Inc. (INM)10% 以上股东买入8,340$10,759

来源:SEC Form 4 申报文件 · 截至 2026-11-13